A simple and reliable method for screening retroviral producer clones without selectable markers

Hum Gene Ther. 1997 Jul 1;8(10):1189-94. doi: 10.1089/hum.1997.8.10-1189.

Abstract

Simplified retroviral vectors that lack dominant selectable markers are being used with increasing frequency. These simplified vectors may offer a number of advantages over selectable marker-containing constructs, including potentially higher titers and less immunogenicity. However, the use of these vectors has been limited by the cumbersome experimental approaches in establishing and characterizing useful producer cell clones. To address this issue, a simple and reliable assay was developed to identify retroviral producer cell lines with or without dominant selectable markers. Producer cells were first generated by standard transfection/transduction and clones isolated by limiting dilution. Supernatant from each clone was then screened by RNA dot blot to identify the best producer clone candidates. The semiquantitative nature of the RNA dot blot assay was validated using a retroviral vector containing neomycin phosphotransferase (neo). Titers obtained by conventional G418-resistant colony forming units/ml (G418(R) cfu/ml) assays strongly correlated with the values by RNA dot blot procedure. RNA dot blot results also correlated well with titers estimated by Southern analysis of HeLa cells transduced with supernatant from each clone. The RNA dot blot technique is a rapid (2 days) and reliable method to screen retroviral producer cells, thereby facilitating the generation and characterization of simplified retroviral producer cell clones.

MeSH terms

  • Animals
  • Biomarkers
  • Blotting, Southern / methods*
  • Cell Line / virology
  • Drug Resistance
  • HeLa Cells / virology
  • Humans
  • In Situ Hybridization / methods
  • RNA, Viral / analysis*
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Reproducibility of Results
  • Retroviridae / genetics*
  • Selection, Genetic

Substances

  • Biomarkers
  • RNA, Viral
  • Recombinant Proteins